Literature DB >> 29134551

The Dangers of Direct-to-Consumer Genetic Testing for Alzheimer's Disease : Comment on "Personal Genomic Testing, Genetic Inheritance, and Uncertainty".

Paul Lacaze1, Jane Tiller2, Joanne Ryan2.   

Abstract

The overarching issue with this case study is poor regulation and quality control over direct-to-consumer genetic testing, delivered in the absence of any medical oversight.

Entities:  

Keywords:  Alzheimer’s disease; Direct-to-consumer testing; Disclosure; Genetics

Mesh：

Year:  2017        PMID： 29134551     DOI： 10.1007/s11673-017-9817-6

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN： 1176-7529            Impact factor:   1.352


  4 in total

1.  The genomic potential of the Aspirin in Reducing Events in the Elderly and Statins in Reducing Events in the Elderly studies.

Authors:  Paul Lacaze; Robyn Woods; Sophia Zoungas; John McNeil
Journal:  Intern Med J       Date:  2017-04       Impact factor: 2.048

2.  Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.

Authors:  John S K Kauwe; Sarah Jacquart; Sumi Chakraverty; Jun Wang; Kevin Mayo; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

3.  Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.

Authors:  Carlos Cruchaga; Gabe Haller; Sumitra Chakraverty; Kevin Mayo; Francesco L M Vallania; Robi D Mitra; Kelley Faber; Jennifer Williamson; Tom Bird; Ramon Diaz-Arrastia; Tatiana M Foroud; Bradley F Boeve; Neill R Graff-Radford; Pamela St Jean; Michael Lawson; Margaret G Ehm; Richard Mayeux; Alison M Goate
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

4.  Pathogenic variants in the healthy elderly: unique ethical and practical challenges.

Authors:  Paul Lacaze; Joanne Ryan; Robyn Woods; Ingrid Winship; John McNeil
Journal:  J Med Ethics       Date:  2017-03-24       Impact factor: 2.903
  4 in total
  2 in total

Review 1.  How does the genomic naive public perceive whole genomic testing for health purposes? A scoping review.

Authors:  Isabella A Sherburn; Keri Finlay; Stephanie Best
Journal:  Eur J Hum Genet       Date:  2022-10-19       Impact factor: 5.351

2.  Study protocol: the Australian genetics and life insurance moratorium-monitoring the effectiveness and response (A-GLIMMER) project.

Authors:  Louise Keogh; Paul Lacaze; Jane Tiller; Aideen McInerney-Leo; Andrea Belcher; Tiffany Boughtwood; Penny Gleeson; Martin Delatycki; Kristine Barlow-Stewart; Ingrid Winship; Margaret Otlowski
Journal:  BMC Med Ethics       Date:  2021-05-21       Impact factor: 2.652
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.